Marat Fudim
MD, MHS, Associate Professor, Cardiology, Duke Clinical Research Institute
Joe Damore, LFACHE
Founder and President, Damore Health Advisors
Managing cardiopulmonary conditions like heart failure is a complex and costly problem, and most current solutions are manual and very resource intensive. The growth of value-based payment models is changing how providers are incentivized. A critical component to driving performance in a value-based arrangement is to provide proactive and effective care management to chronically ill populations. These changes help provide one of the greatest opportunities to improve care for the heart failure (HF) patient population.
Learn about the new paradigm in managing patients with cardiopulmonary conditions such as heart failure—the next generation of care is here with Sensinel by Analog Devices
. Discover the potential clinical and financial benefits of this innovative solution.
Attendees will Learn:
-
- Why is HF so challenging to manage cost-effectively?
- What are the traditional options to manage heart failure?
- What can disruptive technologies like the Sensinel CPM System do to help?
- How can implementing next-generation solutions like the Sensinel CPM System impact clinical quality and financial performance?